Dr Ryonfa Lee
Ryonfa is a trial manager at the CTSU. Since joining the unit in 2012, she has worked on large-scale national and international phase III trials such as ASCEND and REVEAL and is currently working on EMPA-KIDNEY coordinating the study operation in Japan. She is passionate about introducing and implementing the CTSU approach of running streamlined trials in Japan. Along with day-to-day management of running trials, Ryonfa is committed to sharing the expertise and knowledge of trial management and career development for trial managers, and is a member of the Executive Group of the UK Trial Managers’ Network.
Before she joined the CTSU, Ryonfa completed a PhD in Germany in radiation biophysics and conducted research as a post-doc in cancer radiotherapy with charged particles in Germany and the UK. Her BA and Master degrees were awarded in Japan.
Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease
Mayne K. et al, (2023), Journal of the American Society of Nephrology